Which finding would the nurse expect to see in a patient with a hemoglobin level of 8 g/dL? Select all that apply.
One, some, or all responses may be correct.

Choice A rationale:

Methotrexate is a medication used for cancer and autoimmune diseases. It does not chelate iron and is not used to treat iron overload conditions like hemochromatosis.

Choice B rationale:

Deferoxamine is an iron chelating agent used to treat iron overload conditions like hemochromatosis. It binds to excess iron and promotes its excretion from the body, preventing complications such as organ damage.

Choice C rationale:

Ferrous gluconate is an iron supplement used to treat iron deficiency anemia. It would not be appropriate for a patient with hemochromatosis, a condition characterized by iron overload.

Choice D rationale:

Iron dextran complex is another form of intravenous iron used to treat iron deficiency anemia. It is not indicated for treating iron overload conditions like hemochromatosis.

Choice A rationale:

Maximizing cardiac output is a primary goal for patients with chronic heart failure (HF) because it helps improve tissue perfusion and oxygen delivery to meet the body's demands. It is a crucial aspect of managing heart failure and preventing further complications.

Choice B rationale:

Maintaining ideal body weight is important for overall health but is not a primary goal specific to chronic heart failure management.

Choice C rationale:

While exercise is beneficial for heart failure patients, it needs to be tailored to the patient's condition. Performing aerobic exercises daily might not be suitable for all heart failure patients and is not a primary goal.

Choice D rationale:

Maintaining a steady pulse oximetry reading is important, but it is a measure of oxygen saturation in the blood and not a primary goal for managing chronic heart failure.